Enanta製藥 ENTA 深 滬
等待開盤 11-04 09:30:00 美东时间
10.82
-0.140
-1.28%
華盛通- 最 高11.18
- 今 開10.92
- 成交量 38.10万股
- 最 低 10.44
- 昨 收 10.96
- 總市值 2.31亿
- 52周最高 15.34
- 市盈率 靜 --
- 換手率 1.78%
- 52周最低 4.09
- 委 比 -60.44%
- 總股本 2137.66万
- 歷史最高 127.77
- 量 比 0.63
- 振 幅 6.75%
- 歷史最低 4.09
- 每 手 1
- 風險率 1.94%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多W. P. Carey Announces Third Quarter 2025 Financial Results
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- W. P. Carey Inc. (NYSE: WPC) (W. P. Carey or the Company), a net lease real estate investment trust, today reported its financial results for the thir...
10-29 04:05
Entrada Therapeutics to Present at Upcoming Investor Conferences
Entrada Therapeutics announced its participation in two upcoming investor conferences. CEO Dipal Doshi will present at the Jefferies Global Healthcare Conference in London on November 18 and will join a fireside chat at the Evercore Healthcare Conference in Miami on December 3. Live webcasts and 90-day replays will be available on the company's website. Entrada, a clinical-stage biopharmaceutical company, develops novel intracellular therapies fo...
10-28 11:00
Enanta Pharmaceuticals Highlights Promising Zelicapavir Pediatric Results And EDP-323 Post-Exposure Prophylaxis Data For RSV At IDWeek 2025
Zelicapavir Results in Shortened Symptom Duration in Pediatric PatientsEDP-323 is Highly Effective in a Post-Exposure Prophylaxis Setting
10-20 19:04
Enanta Pharmaceuticals to Showcase RSV Drug Data at IDWeek 2025, Highlighting Two Oral Once-Daily Treatments
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and immunological diseases, today announced that data for
10-07 19:14
美股大行评级 | 潜在涨幅162.68%！Ocular Therapeutix获JMP证券升目标价至29美元，维持"跑赢大市"评级
今日重点评级关注：JMP证券：维持Ocular Therapeutix"跑赢大市"评级，目标价从20美元升至29美元；汇丰银行：上调Banco BBVA Argentina评级至"买入"，目标价从21美元下调至17美元
10-02 15:08
Enanta Pharmaceuticals Announces Public Stock Offering
Enanta Pharmaceuticals ( ($ENTA) ) has issued an update. On September 30, 2025,...
10-02 05:06
Is The Nike Turnaround Story In Play?
Nike delivers a mixed but encouraging quarter, and a turnaround narrative is starting to take shape.
10-02 00:11
美股大行评级 | 潜在涨幅超31%！摩根大通维持通用汽车"超配"评级，目标价从60美元升至80美元
今日重点评级关注：Maxim Group：上调Adial Pharmaceuticals评级至"买入"，目标价1.5美元；BTIG：维持Climb Bio"买入"评级，目标价从7美元升至8美元
10-01 20:13
Enanta pharmaceuticals prices $65M common stock offering
Enanta Pharmaceuticals (NASDAQ:ENTA) has priced its public offering of 6.5M common shares at $10.00 per share for gross proceeds of $65.0M. The company has granted the underwriters a 30-day option to...
10-01 12:50
美股牛股 | Enanta制药飙涨92%！新药获FDA快速通道资格；加密货币股Bakkt大涨42%
Enanta制药单日飙涨92%！旗下新药获FDA快速通道资格；比特币快速反弹至11.4万美元上方，加密货币股Bakkt隔夜大涨42%>>
09-30 17:15
